Middle East and Africa Methadone Market was worth USD xx billion in 2018and estimated to be growing at a CAGR of xx%, to reach USD xx billion by 2023. Methadone is an opioid, which is sold under the name of Dolophine among others. It is used in treating pain and as a maintenance therapy and to help with tapering in people suffering from opioid dependence.

Methadone helps in reducing withdrawal symptoms and cravings in people with opioid addiction. Also, it helps in blocking the high sensation in parts of spinal cord and brain which are caused by using opiates. Methadone helps in managing additions in patients who are dependent on morphine, heroin or prescription painkillers. It can be used for long or short durations which depends on the necessity of patient.

The driving factors of Middle East and Africa Methadone market are growth in the number of people who are addicted to several opioids such as morphine and heroin. Also, growth in awareness towards the use of these medications and growth in number of people who are seeking help to detoxify their system boosts the market growth. Additionally, since the medication can be used for managing pain, growth in the number of people affected with chronic pain is presumed to raise the demand for this drug. However, the market is constrained due to factors such as side-effects which are caused by the usage of methadone.

The Middle East and Africa Methadone market is segmented based on mode of administration and application. By application, the market is divided into operation, detoxification and others. By mode of administration, the market is segmented into injections and oral medicine. Oral medicine is further divided into tablets and liquid.

The market in the region can be geographically segmented into Middle East and Africa region. Factors such as rising incidence of addiction and growing incidence of people using methadone of chronic pains are expected to drive the market growth in the region.

Some of the major players in the market are Diskets, Methadoes, Aurolife Pharma LLC, Macfarlan Smith, VistaPharm, Qinghai Pharm, CentralPharm, Mallinckrodt and Roxane (Boehringer Ingelheim) among others.

1. Introduction

1.1 Market Definition

1.2 Study Deliverables

1.3 Base Currency, Base Year and Forecast Periods

1.4 General Study Assumptions

2. Research Methodology

2.1 Introduction

2.2 Research Phases

2.2.1 Secondary Research

2.2.2 Primary Research

2.2.3 Econometric Modelling

2.2.4 Expert Validation

2.3 Analysis Design

2.4 Study Timeline

3. Overview

3.1 Executive Summary

3.2 Key Inferences

3.3 Epidemology

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

4.1 Market Drivers

4.2 Market Restraints

4.3 Key Challenges

4.4 Current Opportunities in the Market

5. Market Segmentation

5.1 Application

5.1.1 Operation

5.1.2 Detoxification

5.1.3 Others

5.1.4 Y-o-Y Growth Analysis, By Application

5.1.5 Market Attractiveness Analysis, By Application

5.1.6 Market Share Analysis, By Application

5.2 Mode of Administration

5.2.1 Injections

5.2.2 Oral Medicine

5.2.2.1 Tablets

5.2.2.2 Liquid

5.2.3 Y-o-Y Growth Analysis, By Mode of Administration

5.2.4 Market Attractiveness Analysis, By Mode of Administration

5.2.5 Market Share Analysis, By Mode of Administration

6. Geographical Analysis

6.1 Introduction

6.1.1 Regional Trends

6.1.2 Impact Analysis

6.1.3 Y-o-Y Growth Analysis

6.1.3.1 By Application

6.1.3.2 By Mode of Administration

6.1.4 Market Attractiveness Analysis

6.1.4.1 By Application

6.1.4.2 By Mode of Administration

6.1.5 Market Share Analysis

6.1.5.1 By Application

6.1.5.2 By Mode of Administration

6.2 Middle-East

6.3 Africa

7. Strategic Analysis

7.1 PESTLE analysis

7.1.1 Political

7.1.2 Economic

7.1.3 Social

7.1.4 Technological

7.1.5 Legal

7.1.6 Environmental

7.2 Porter’s Five analysis

7.2.1 Bargaining Power of Suppliers

7.2.2 Bargaining Power of Consumers

7.2.3 Threat of New Entrants

7.2.4 Threat of Substitute Products and Services

7.2.5 Competitive Rivalry within the Industry

8. Market Leaders' Analysis

8.1 Diskets

8.1.1 Overview

8.1.2 Product Analysis

8.1.3 Financial analysis

8.1.4 Recent Developments

8.1.5 SWOT analysis

8.1.6 Analyst View

8.2 Methadoes

8.3 Aurolife Pharma LLC

8.4 Macfarlan Smith

8.5 VistaPharm

8.6 Qinghai Pharm

8.7 CentralPharm

8.8 Mallinckrodt

8.9 Roxane

9. Competitive Landscape

9.1 Market share analysis

9.2 Merger and Acquisition Analysis

9.3 Agreements, collaborations and Joint Ventures

9.4 New Product Launches

10. Market Outlook and Investment Opportunities

Appendix

a) List of Tables

b) List of Figures

Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped

Segment-level analysis in terms by mode of administration with market size forecasts and estimations to detect key areas of industry growth in detail

Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics

Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis

Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development

A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment

Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies

An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions

Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

S.NO

Title

Price

Licence Type

Add To Cart

Note: All chapters are avaliable only with corporate licence

Middle East and Africa Methadone Market By Application, From 2018-2023 ( USD Million )

Middle East and Africa Operation Market By Region, From 2018-2023 ( USD Million )

Middle East and Africa Detoxification Market By Region, From 2018-2023 ( USD Million )

Middle East and Africa Others Market By Region, From 2018-2023 ( USD Million )

Middle East and Africa Methadone Market By Mode of Administration, From 2018-2023 ( USD Million )

Middle East and Africa Injections Market By Region, From 2018-2023 ( USD Million )

Middle East and Africa Oral Medicine Market By Region, From 2018-2023 ( USD Million )

Middle East Methadone Market By Application, From 2018-2023 ( USD Million )

Middle East Methadone Market By Mode of Administration, From 2018-2023 ( USD Million )